Chronic endophthalmitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:279891H44.0H44.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Chronic endophthalmitis is a rare, persistent inflammatory and infectious condition affecting the interior of the eye (the vitreous cavity and/or aqueous humor). Unlike acute endophthalmitis, which presents dramatically within days, chronic endophthalmitis develops insidiously over weeks to months, often following ocular surgery (most commonly cataract extraction with intraocular lens implantation), penetrating trauma, or, less frequently, through hematogenous spread from a distant infection. The condition is typically caused by low-virulence organisms, particularly Cutibacterium acnes (formerly Propionibacterium acnes), coagulase-negative staphylococci, and certain fungi such as Candida or Aspergillus species. Key symptoms include progressive, painless or mildly painful blurred vision, chronic low-grade anterior chamber inflammation (flare and cells), vitreous haze or opacities, and the formation of white plaques on the intraocular lens or within the capsular bag. Patients may experience recurrent episodes of inflammation that partially respond to topical corticosteroids but relapse upon discontinuation. Granulomatous keratic precipitates and hypopyon may also be observed. Because of its indolent course, chronic endophthalmitis is frequently misdiagnosed as chronic noninfectious uveitis, leading to significant delays in appropriate treatment. Treatment depends on the causative organism and typically involves a combination of intravitreal antibiotic or antifungal injections, and in many cases, pars plana vitrectomy with removal of the intraocular lens and capsular bag to eliminate sequestered organisms. Systemic antimicrobial therapy may also be employed. Early and accurate diagnosis through vitreous or aqueous sampling with culture and polymerase chain reaction (PCR) testing is critical for optimal outcomes. Despite treatment, visual prognosis is variable, and some patients may experience permanent vision loss due to chronic inflammation and secondary complications such as cystoid macular edema, retinal detachment, or glaucoma.

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Chronic endophthalmitis.

View clinical trials →

No actively recruiting trials found for Chronic endophthalmitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Chronic endophthalmitis community →

No specialists are currently listed for Chronic endophthalmitis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Chronic endophthalmitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Chronic endophthalmitisForum →

No community posts yet. Be the first to share your experience with Chronic endophthalmitis.

Start the conversation →

Latest news about Chronic endophthalmitis

No recent news articles for Chronic endophthalmitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Chronic endophthalmitis

What is Chronic endophthalmitis?

Chronic endophthalmitis is a rare, persistent inflammatory and infectious condition affecting the interior of the eye (the vitreous cavity and/or aqueous humor). Unlike acute endophthalmitis, which presents dramatically within days, chronic endophthalmitis develops insidiously over weeks to months, often following ocular surgery (most commonly cataract extraction with intraocular lens implantation), penetrating trauma, or, less frequently, through hematogenous spread from a distant infection. The condition is typically caused by low-virulence organisms, particularly Cutibacterium acnes (former

At what age does Chronic endophthalmitis typically begin?

Typical onset of Chronic endophthalmitis is adult. Age of onset can vary across affected individuals.